Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients

Salerno, D. M., Jennings, D. L., Lange, N. W., Kovac, D. (Bley), Shertel, T., Chen, J. K., Hedvat, J., Scheffert, J., Brown Jr, R. S., & Pereira, M. R. (2022). Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients. American Journal of Transplantation, 22(8), 2083–2088. https://doi.org/10.1111/ajt.17027
Authors:
David M. Salerno
Douglas L. Jennings
Nicholas W. Lange
Danielle Kovac
Tara Shertel
Justin K. Chen
Jessica Hedvat
Jenna Scheffert
Robert S. Brown
Marcus R. Pereira
Affiliated Authors:
David M. Salerno
Douglas L. Jennings
Nicholas W. Lange
Danielle Kovac
Tara Shertel
Justin K. Chen
Jessica Hedvat
Jenna Scheffert
Marcus R. Pereira
Columbia Affiliation:
Subjects:
Lactams (MeSH)
Leucine (MeSH)
Nitriles (MeSH)
Proline (MeSH)
Ritonavir (MeSH)
Transplant Recipients (MeSH)
COVID-19 Drug Treatment (MeSH)
Author Keywords:
clinical research/practice
drug interaction
immunosuppressant
immunosuppression/immune modulation
infection and infectious agents-viral: sars-cov-2/covid-19
pharmacology
solid organ transplantation
infection and infectious agents—viral: sars-cov-2/covid-19
elink
Publication Type:
Article
Unique ID:
10.1111/ajt.17027
PMID:
35278260
DOI:
10.1111/ajt.17027
Journal:
American Journal of Transplantation
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View PubMed Record
View Web of Science Record

Record Created: